Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283838207> ?p ?o ?g. }
- W4283838207 endingPage "2942" @default.
- W4283838207 startingPage "2933" @default.
- W4283838207 abstract "Abstract Aims To measure the prevalence and changes in smokers’ discussions with health professionals (HPs) about nicotine vaping products (NVPs) and HPs’ recommendations about NVPs between 2016 and 2020, and their associations with tobacco product use transitions. Design Cohort study using multinomial logistic regression analyses on data from waves 1 (2016), 2 (2018) and 3 (2020) from the International Tobacco Control Four Country Smoking and Vaping Surveys. Setting Four countries with varying NVP regulatory environments: ‘most restrictive’ (Australia), ‘somewhat restrictive’ (Canada) and ‘less restrictive’ (England and the United States). Participants Adult exclusive daily smokers who did not report NVP use at the time of their baseline survey and had visited a HP in the last 12–24 months. Prevalence data came from 4125, 4503 and 4277 respondents, respectively, for each year. Longitudinal data were from 4859 respondents who participated in at least two consecutive surveys. Measurements Prevalence of self‐reported discussions with HPs and recommendations from HPs about NVPs. Longitudinal transitions from smoking to vaping (either exclusively or concurrently with smoking) and quitting (regardless of NVP uptake). Findings The prevalence of NVP discussions was low among countries with varying regulatory environments and study waves (range = 1.4–6.2%). In 2020, a low percentage of smokers who discussed NVPs with a HP reported that their HPs recommended they use NVPs in the United States (14.7%), Australia (20.2%), Canada (25.7%), with a higher percentage in England (55.7%) where clinical guidelines for smoking cessation include NVPs. Compared with 12.0% of smokers who reported no discussion, 37.0% of those whose HPs recommended NVPs transitioned to vaping at follow‐up. Transition to quitting was 9.6% with HPs’ recommendation of NVPs versus 13.5% without discussion, a non‐significant difference. Conclusions In Australia, Canada, England and the United States between 2016 and 2020, health professionals’ discussions with smokers about nicotine vaping products (NVPs) were infrequent. NVP discussions were associated with NVP uptake, but not with quitting smoking." @default.
- W4283838207 created "2022-07-07" @default.
- W4283838207 creator A5003496773 @default.
- W4283838207 creator A5019410467 @default.
- W4283838207 creator A5031063835 @default.
- W4283838207 creator A5032666703 @default.
- W4283838207 creator A5045937794 @default.
- W4283838207 creator A5055271354 @default.
- W4283838207 creator A5060863030 @default.
- W4283838207 creator A5071283818 @default.
- W4283838207 creator A5078470052 @default.
- W4283838207 date "2022-07-14" @default.
- W4283838207 modified "2023-09-26" @default.
- W4283838207 title "Adult smokers’ discussions about vaping with health professionals and subsequent behavior change: a cohort study" @default.
- W4283838207 cites W1785656757 @default.
- W4283838207 cites W1905498127 @default.
- W4283838207 cites W2028655348 @default.
- W4283838207 cites W2064456893 @default.
- W4283838207 cites W2083926024 @default.
- W4283838207 cites W2129834677 @default.
- W4283838207 cites W2132026198 @default.
- W4283838207 cites W2133098281 @default.
- W4283838207 cites W2135504811 @default.
- W4283838207 cites W2143000453 @default.
- W4283838207 cites W2148690562 @default.
- W4283838207 cites W2176342060 @default.
- W4283838207 cites W2403863284 @default.
- W4283838207 cites W2405992713 @default.
- W4283838207 cites W2509849513 @default.
- W4283838207 cites W2516346085 @default.
- W4283838207 cites W2551283707 @default.
- W4283838207 cites W2557577182 @default.
- W4283838207 cites W2604411640 @default.
- W4283838207 cites W2619826769 @default.
- W4283838207 cites W2734673102 @default.
- W4283838207 cites W2736764911 @default.
- W4283838207 cites W2744343098 @default.
- W4283838207 cites W2751759855 @default.
- W4283838207 cites W2790008079 @default.
- W4283838207 cites W2884357926 @default.
- W4283838207 cites W2891418602 @default.
- W4283838207 cites W2905067783 @default.
- W4283838207 cites W2912904794 @default.
- W4283838207 cites W2913337886 @default.
- W4283838207 cites W2913847031 @default.
- W4283838207 cites W2918149110 @default.
- W4283838207 cites W2999111579 @default.
- W4283838207 cites W3045743737 @default.
- W4283838207 cites W3126088119 @default.
- W4283838207 cites W3144447400 @default.
- W4283838207 doi "https://doi.org/10.1111/add.15994" @default.
- W4283838207 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35792058" @default.
- W4283838207 hasPublicationYear "2022" @default.
- W4283838207 type Work @default.
- W4283838207 citedByCount "1" @default.
- W4283838207 countsByYear W42838382072023 @default.
- W4283838207 crossrefType "journal-article" @default.
- W4283838207 hasAuthorship W4283838207A5003496773 @default.
- W4283838207 hasAuthorship W4283838207A5019410467 @default.
- W4283838207 hasAuthorship W4283838207A5031063835 @default.
- W4283838207 hasAuthorship W4283838207A5032666703 @default.
- W4283838207 hasAuthorship W4283838207A5045937794 @default.
- W4283838207 hasAuthorship W4283838207A5055271354 @default.
- W4283838207 hasAuthorship W4283838207A5060863030 @default.
- W4283838207 hasAuthorship W4283838207A5071283818 @default.
- W4283838207 hasAuthorship W4283838207A5078470052 @default.
- W4283838207 hasConcept C105795698 @default.
- W4283838207 hasConcept C117568660 @default.
- W4283838207 hasConcept C119857082 @default.
- W4283838207 hasConcept C126322002 @default.
- W4283838207 hasConcept C138816342 @default.
- W4283838207 hasConcept C142724271 @default.
- W4283838207 hasConcept C144024400 @default.
- W4283838207 hasConcept C149923435 @default.
- W4283838207 hasConcept C151956035 @default.
- W4283838207 hasConcept C159110408 @default.
- W4283838207 hasConcept C201903717 @default.
- W4283838207 hasConcept C27403532 @default.
- W4283838207 hasConcept C2777843972 @default.
- W4283838207 hasConcept C2777895361 @default.
- W4283838207 hasConcept C2780832096 @default.
- W4283838207 hasConcept C2993680756 @default.
- W4283838207 hasConcept C33923547 @default.
- W4283838207 hasConcept C41008148 @default.
- W4283838207 hasConcept C71924100 @default.
- W4283838207 hasConcept C72563966 @default.
- W4283838207 hasConcept C99454951 @default.
- W4283838207 hasConceptScore W4283838207C105795698 @default.
- W4283838207 hasConceptScore W4283838207C117568660 @default.
- W4283838207 hasConceptScore W4283838207C119857082 @default.
- W4283838207 hasConceptScore W4283838207C126322002 @default.
- W4283838207 hasConceptScore W4283838207C138816342 @default.
- W4283838207 hasConceptScore W4283838207C142724271 @default.
- W4283838207 hasConceptScore W4283838207C144024400 @default.
- W4283838207 hasConceptScore W4283838207C149923435 @default.
- W4283838207 hasConceptScore W4283838207C151956035 @default.
- W4283838207 hasConceptScore W4283838207C159110408 @default.
- W4283838207 hasConceptScore W4283838207C201903717 @default.